Bolzon Bradley J Phd - Net Worth and Insider Trading

Bolzon Bradley J Phd Net Worth

The estimated net worth of Bolzon Bradley J Phd is at least $47 Million dollars as of 2024-11-10. Bolzon Bradley J Phd is the Director of CRISPR Therapeutics AG and owns about 498,558 shares of CRISPR Therapeutics AG (CRSP) stock worth over $26 Million. Bolzon Bradley J Phd is also the Director, 10% Owner of Black Diamond Therapeutics Inc and owns about 6,471,188 shares of Black Diamond Therapeutics Inc (BDTX) stock worth over $21 Million. Details can be seen in Bolzon Bradley J Phd's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Bolzon Bradley J Phd has not made any transactions after 2021-07-19 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Bolzon Bradley J Phd

To

Bolzon Bradley J Phd Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Bolzon Bradley J Phd owns 10 companies in total, including Black Diamond Therapeutics Inc (BDTX) , CRISPR Therapeutics AG (CRSP) , and Flexion Therapeutics Inc (FLXN) among others .

Click here to see the complete history of Bolzon Bradley J Phd’s form 4 insider trades.

Insider Ownership Summary of Bolzon Bradley J Phd

Ticker Comapny Transaction Date Type of Owner
BDTX Black Diamond Therapeutics Inc 2020-11-30 director
CRSP CRISPR Therapeutics AG 2021-07-19 director
FLXN Flexion Therapeutics Inc 2016-06-08 10 percent owner
LIMIT LIMIT 2016-05-23 10 percent owner
LIMIT LIMIT 2014-10-07 10 percent owner
LIMIT LIMIT 2014-11-18 10 percent owner
LIMIT LIMIT 2006-05-09 10 percent owner
LIMIT LIMIT 2006-03-13 other: Former 10% Holder
LIMIT LIMIT 2021-06-23 director & 10 percent owner
LIMIT LIMIT 2014-11-18 10 percent owner

Bolzon Bradley J Phd Latest Holdings Summary

Bolzon Bradley J Phd currently owns a total of 2 stocks. Among these stocks, Bolzon Bradley J Phd owns 498,558 shares of CRISPR Therapeutics AG (CRSP) as of July 19, 2021, with a value of $26 Million and a weighting of 54.71%. Bolzon Bradley J Phd also owns 6,471,188 shares of Black Diamond Therapeutics Inc (BDTX) as of November 30, 2020, with a value of $21 Million and a weighting of 45.29%.

Latest Holdings of Bolzon Bradley J Phd

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
CRSP CRISPR Therapeutics AG 2021-07-19 498,558 51.59 25,720,607
BDTX Black Diamond Therapeutics Inc 2020-11-30 6,471,188 3.29 21,290,209

Holding Weightings of Bolzon Bradley J Phd


Bolzon Bradley J Phd Form 4 Trading Tracker

According to the SEC Form 4 filings, Bolzon Bradley J Phd has made a total of 18 transactions in CRISPR Therapeutics AG (CRSP) over the past 5 years, including 0 buys and 18 sells. The most-recent trade in CRISPR Therapeutics AG is the sale of 10,000 shares on July 19, 2021, which brought Bolzon Bradley J Phd around $1 Million.

According to the SEC Form 4 filings, Bolzon Bradley J Phd has made a total of 15 transactions in Black Diamond Therapeutics Inc (BDTX) over the past 5 years, including 1 buys and 14 sells. The most-recent trade in Black Diamond Therapeutics Inc is the sale of 10,393 shares on November 30, 2020, which brought Bolzon Bradley J Phd around $344,528.

Insider Trading History of Bolzon Bradley J Phd

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Bolzon Bradley J Phd Trading Performance

GuruFocus tracks the stock performance after each of Bolzon Bradley J Phd's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Bolzon Bradley J Phd is 13.01%. GuruFocus also compares Bolzon Bradley J Phd's trading performance to market benchmark return within the same time period. The performance of stocks bought by Bolzon Bradley J Phd within 3 months outperforms 2 times out of 2 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Bolzon Bradley J Phd's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Bolzon Bradley J Phd

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
1 out of 2 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 8.5 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 11.04 LIMIT LIMIT LIMIT LIMIT LIMIT

Bolzon Bradley J Phd Ownership Network

Ownership Network List of Bolzon Bradley J Phd

No Data

Ownership Network Relation of Bolzon Bradley J Phd

Insider Network Chart

Bolzon Bradley J Phd Owned Company Details

What does Black Diamond Therapeutics Inc do?

Who are the key executives at Black Diamond Therapeutics Inc?

Bolzon Bradley J Phd is the director of Black Diamond Therapeutics Inc. Other key executives at Black Diamond Therapeutics Inc include 10 percent owner Versant Venture Capital Vi, L.p. , 10 percent owner Biotech Growth N V , and director & 10 percent owner Ali Behbahani .

Black Diamond Therapeutics Inc (BDTX) Insider Trades Summary

Over the past 18 months, Bolzon Bradley J Phd made no insider transaction in Black Diamond Therapeutics Inc (BDTX). Other recent insider transactions involving Black Diamond Therapeutics Inc (BDTX) include a net purchase of 3,140,000 shares made by Biotech Growth N V , a net purchase of 1,000,000 shares made by Ali Behbahani , and a net purchase of 935,850 shares made by Ra Capital Healthcare Fund Lp .

In summary, during the past 3 months, insiders sold 221,600 shares of Black Diamond Therapeutics Inc (BDTX) in total and bought 0 shares, with a net sale of 221,600 shares. During the past 18 months, 246,600 shares of Black Diamond Therapeutics Inc (BDTX) were sold and 5,075,850 shares were bought by its insiders, resulting in a net purchase of 4,829,250 shares.

Black Diamond Therapeutics Inc (BDTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Black Diamond Therapeutics Inc Insider Transactions

No Available Data

Bolzon Bradley J Phd Mailing Address

Above is the net worth, insider trading, and ownership report for Bolzon Bradley J Phd. You might contact Bolzon Bradley J Phd via mailing address: One Sansome Street, Suite 3630, San Francisco Ca 94104.